Arkolith/Insider Trading/SRPT/Form 4

Ingram Douglas S

Chief Executive Officer, DirectorSarepta Therapeutics, Inc. (SRPT) · full profile →Form 4 · filed Dec 9, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 7, 2025Grant(A)73K—$0563K
Dec 7, 2025Grant(A)50K—$0490K
Dec 7, 2025Grant(A)50K—$0440K
Dec 7, 2025Grant(A)270K—$0929K
Dec 7, 2025Grant(A)97K—$0660K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-313184) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML